Literature DB >> 23450031

Prognostic factors for premature growth plate arrest as a complication of the surgical treatment of fractures of the medial malleolus in children.

D V Petratos1, M Kokkinakis, E G Ballas, J N Anastasopoulos.   

Abstract

McFarland fractures of the medial malleolus in children, also classified as Salter-Harris Type III and IV fractures, are associated with a high incidence of premature growth plate arrest. In order to identify prognostic factors for the development of complications we reviewed 20 children with a McFarland fracture that was treated surgically, at a mean follow-up of 8.9 years (3.5 to 17.4). Seven children (35%) developed premature growth arrest with angular deformity. The mean American Orthopaedic Foot and Ankle Society Ankle-Hindfoot Scale for all patients was 98.3 (87 to 100) and the mean modified Weber protocol was 1.15 (0 to 5). There was a significant correlation between initial displacement (p = 0.004) and operative delay (p = 0.007) with premature growth arrest. Both risk factors act independently and additively, such that all children with both risk factors developed premature arrest whereas children with no risk factor did not. We recommend that fractures of the medial malleolus in children should be treated by anatomical reduction and screw fixation within one day of injury.

Entities:  

Mesh:

Year:  2013        PMID: 23450031     DOI: 10.1302/0301-620X.95B3.29410

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  2 in total

1.  Concurrent ipsilateral Tillaux fracture and medial malleolar fracture in adolescents: management and outcome.

Authors:  Quanwen Yuan; Zhixiong Guo; Xiaodong Wang; Jin Dai; Fuyong Zhang; Jianfeng Fang; Chunhua Yin; Wentao Yu; Yunfang Zhen
Journal:  J Orthop Surg Res       Date:  2020-09-17       Impact factor: 2.359

2.  Case report: Reconstruction of distal medial tibial epiphysis using iliac crest apophyseal autograft.

Authors:  Chengming Zhu; BaoJie Shi; Saroj Rai; Haobo Zhong; Xin Tang
Journal:  Front Pediatr       Date:  2022-08-12       Impact factor: 3.569

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.